Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | GSK3A | P49840 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.30 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2836974 | 0.89 | GAA (0.44) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| SCHEMBL28493053 | 0.88 | GAA (0.38) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| Ammonia Solution, Strong SCHEMBL11162445 | 0.88 | GAA (0.43) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| SCHEMBL29134171 | 0.85 | GAA (0.35) | ALDH1A1GAAMGAMSIMGAM2 | |
| SCHEMBL5851722 | 0.82 | GAA (0.41) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| SCHEMBL6236677 | 0.81 | GAA (0.38) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| SCHEMBL28982401 | 0.81 | GAA (0.38) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| Ammonia Solution, Strong SCHEMBL27498859 | 0.81 | GAA (0.42) | ALDH1A1LMNAGAAMGAMSI | |
| SCHEMBL27612884 | 0.79 | GAA (0.39) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| SCHEMBL1071007 | 0.79 | ALDH1A1 (0.40) | ALDH1A1LMNAHSD17B10GAAMGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1969 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226053-A9 | Compositions for ophthalmic care | Rebio Technologies Oy (FI) | 2024-07-11 | — | — | US | claimed |
| US-11993705-B2 | High PLA content plastic material comprising a citrate ester | CARBIOLICE (FR) | 2024-05-28 | — | — | US | claimed |
| US-20240130997-A1 | Compositions for ophthalmic care | REBIO TECH OY (FI) | 2024-04-25 | — | — | US | claimed |
| EP-4294366-A1 | COMPOSITIONS FOR OPHTHALMIC CARE | Rebio Technologies Oy (FI) | 2023-12-27 | — | — | EP | claimed |
| EP-3932407-B1 | ENTERIC COATED TABLET COMPOSITION COMPRISING TETRAMETHYLPYRAZINE NITRONE | GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD (CN) | 2023-10-18 | — | — | EP | claimed |
| CN-116367912-A | Membranes made using fine powders | 阿科玛股份有限公司 | 2023-06-30 | — | — | CN | claimed |
| US-20230203274-A1 | ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION,MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-06-29 | — | — | US | claimed |
| US-20230078906-A1 | SUSTAINED RELEASE DEXAMETHASONE FORMULATION | ICON BIOSCIENCE, INC. | 2023-03-16 | — | — | US | claimed |
| EP-4139385-A1 | USE OF INORGANIC SULPHITES AND/OR THIOSULPHATES FOR STABILISING ALIPHATIC POLYESTERS, STABILISED MOULDING COMPOSITIONS AND MOULDING COMPOSITIONS AND MOULDED PARTS PRODUCED THEREFROM | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-03-01 | — | — | EP | claimed |
| EP-4139388-A1 | USE OF HYDROXYCARBOXYLIC ACID SALTS FOR STABILIZING THERMOPLASTIC CONDENSATION POLYMERS, STABILIZED MOULDING COMPOSITIONS AND MOULDING COMPOSITIONS PRODUCED THEREFROM | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-03-01 | — | — | EP | claimed |
| WO-1993020110-A1 | ESTERIFIED STARCH COMPOSITION | PARKE-DAVIS & COMPANY (US) | 1993-10-14 | — | — | WO | claimed |
| US-5202128-A | Oral administering | F. H. FAULDING & CO. LIMITED (AU) | 1993-04-13 | — | — | US | claimed |
| US-5196203-A | Treating cardiotonic, diuretic or respiratory conditions | F. H. FAULDING & CO. LIMITED (AU) | 1993-03-23 | — | — | US | claimed |
| WO-1991018078-A1 | CARBOXY/CARBOXYLATE DISUBSTITUTED ESTERS AS EDIBLE FAT MIMETICS | NABISCO, INC. (US) | 1991-11-28 | — | — | WO | claimed |
| EP-0377517-A2 | Theophylline dosage form | F.H. FAULDING & CO. LIMITED (AU) | 1990-07-11 | — | — | EP | claimed |
| EP-0377518-A2 | Sustained release pharmaceutical composition | F.H. FAULDING & CO. LIMITED (AU) | 1990-07-11 | — | — | EP | claimed |
| US-4917899-A | ORAL ADMINISTRATION, TIME RELEASE AGENT; | ELAN CORPORATION PLC (IE) | 1990-04-17 | — | — | US | claimed |
| US-4894240-A | CORES, MEMBRANES, MULTILAYER, TIME-RELEASE AGENTS | ELAN CORPORATION PLC (IE) | 1990-01-16 | — | — | US | claimed |
| US-4891230-A | SUSTAINED RELEASE | ELAN CORPORATION PLC (IE) | 1990-01-02 | — | — | US | claimed |
| EP-0327295-A2 | Tetracycline dosage form | F.H. FAULDING & CO. LTD. (AU) | 1989-08-09 | — | — | EP | claimed |